Ghita Meknassi Salime
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ghita Meknassi Salime has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Nihal Bhirich
Mohammed V University of Rabat
3 shared publications - Younes Rahali
Health Products Formulation and Quality Control Team, Faculty of Medicine and Pharmacy Mohammed V University Rabat Morocco
2 shared publications - Abdelghani Asraoui
Antipoison and Pharmacovigilance Center, Rabat, Morocco
1 shared publication Ali Cherif Chefchaouni
Faculty of Medicine and pharmacy, Mohammed V University, Rabat, Morocco; Ibn Sina University Hospital, Rabat, Morocco
1 shared publication- Ali Cherif Chefchaouni
Laboratory of drug sciences, Department of Pharmacy, Faculty of Medicine, Pharmacy, and Dental Medicine of Fez, Sidi Mohamed Ben Abdellah University, Fez, Morocco
1 shared publication - Casimir Adade Adade
Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco
1 shared publication
Latest Publications
- 1 October 2025
- Published by Bentham Science Publishers Ltd. in Current Nanomedicine
- Vol. 15 (5) , 609-623
Carbon Nanotubes: New Chemotherapeutic Drug Delivery Systems for Targeted Cancer Treatments
The complexity of the management of cancerous conditions requires innovative strategies, including the pharmacotechnical optimization of treatments. The improvement of galenic forms, or more generally of drug delivery, represents a rapidly developing area of research, particularly in oncology, in order to remedy side effects and drug resistance remains a worrying problem. Carbon nanotubes CNTs consist of thin sheets of benzene carbons coiled into a seamless tubular structure. These CNTs have remarkable size and surface properties that make them the ideal vehicle for targeted and selective drug delivery. Different in vitro and in vivo experiments have proven that these particles can be easily modified in such a way that the chemical drug can be delivered directly to the tumor site. Additionally, different types of ligands can be loaded on the surface of CNTs to improve selectivity or modulate drug release. On the other hand, advances in carbon nanotubes could well lead to a more effective understanding of biological and physicochemical processes. This will make it possible to find compounds more compatible with carbon nanotube technology and facilitate their use.
- 1 October 2025
- Published by Bentham Science Publishers Ltd. in Current Nanomedicine
- Vol. 15 (5) , 609-623
Carbon Nanotubes: New Chemotherapeutic Drug Delivery Systems for Targeted Cancer Treatments
The complexity of the management of cancerous conditions requires innovative strategies, including the pharmacotechnical optimization of treatments. The improvement of galenic forms, or more generally of drug delivery, represents a rapidly developing area of research, particularly in oncology, in order to remedy side effects and drug resistance remains a worrying problem. Carbon nanotubes CNTs consist of thin sheets of benzene carbons coiled into a seamless tubular structure. These CNTs have remarkable size and surface properties that make them the ideal vehicle for targeted and selective drug delivery. Different in vitro and in vivo experiments have proven that these particles can be easily modified in such a way that the chemical drug can be delivered directly to the tumor site. Additionally, different types of ligands can be loaded on the surface of CNTs to improve selectivity or modulate drug release. On the other hand, advances in carbon nanotubes could well lead to a more effective understanding of biological and physicochemical processes. This will make it possible to find compounds more compatible with carbon nanotube technology and facilitate their use.
- 15 July 2025
- Published by Springer Nature in Vegetos
- p. 1-13
Bibliometric analysis of chemometric research applied to phytomedicine: ensuring quality control of medicinal plants
- 15 July 2025
- Published by Springer Nature in Vegetos
- p. 1-13
Bibliometric analysis of chemometric research applied to phytomedicine: ensuring quality control of medicinal plants
- 30 June 2025
- Published by Bentham Science Publishers Ltd. in Current Drug Safety
- Vol. 20, 1-12
Enhancing Pharmacovigilance in Pharmaceutical Companies: A Comparative Study of Electronic Reporting Before and After Implementation
Background: Since 2016, Moroccan pharmaceutical companies have been required to report adverse effects linked to their medicines. Initially, reports were submitted using the CIOMS form, sent by normal mail to le Centre Antipoison et de Pharmacovigilance du Maroc, then using XML files in ICH E2B format, sent electronically. In 2021, a "vigiflow e-reporting for industry" standardized online reporting system was implemented. The primary objective of this study was to evaluate the pharmaceutical companies'; use of electronic reporting. Secondarily, the study aimed to assess the quality of adverse drug reaction reports by comparing completeness scores across the three reporting means. Methods: All individual case safety reports sent by pharmaceutical companies from January 1, 2019, to December 31, 2023, were extracted from Vigibase®. A quantitative and qualitative analysis was conducted, and a statistical comparison of data was performed using p-values. VigiGrade completeness score was calculated for a sample size selected. Results: The highest number of reports were from E-reporting (50%), followed by CIOMS (29%) and E2B (21%). Between 2019 and 2021, CIOMS and E2B notifications decreased along with reporting laboratories. However, after 2021, electronic reporting increased steadily alongside reporting companies. Comparing vigiGrade completeness score across reporting means revealed no statistically significant differences (p = 0.094 > 0.05). Conclusion: Electronic reporting shows quantitative effectiveness and consistent quality. Its adoption remains limited and requires continuous strengthening, particularly through increased awareness among pharmaceutical companies
- 30 June 2025
- Published by Bentham Science Publishers Ltd. in Current Drug Safety
- Vol. 20, 1-12
Enhancing Pharmacovigilance in Pharmaceutical Companies: A Comparative Study of Electronic Reporting Before and After Implementation
Background: Since 2016, Moroccan pharmaceutical companies have been required to report adverse effects linked to their medicines. Initially, reports were submitted using the CIOMS form, sent by normal mail to le Centre Antipoison et de Pharmacovigilance du Maroc, then using XML files in ICH E2B format, sent electronically. In 2021, a "vigiflow e-reporting for industry" standardized online reporting system was implemented. The primary objective of this study was to evaluate the pharmaceutical companies'; use of electronic reporting. Secondarily, the study aimed to assess the quality of adverse drug reaction reports by comparing completeness scores across the three reporting means. Methods: All individual case safety reports sent by pharmaceutical companies from January 1, 2019, to December 31, 2023, were extracted from Vigibase®. A quantitative and qualitative analysis was conducted, and a statistical comparison of data was performed using p-values. VigiGrade completeness score was calculated for a sample size selected. Results: The highest number of reports were from E-reporting (50%), followed by CIOMS (29%) and E2B (21%). Between 2019 and 2021, CIOMS and E2B notifications decreased along with reporting laboratories. However, after 2021, electronic reporting increased steadily alongside reporting companies. Comparing vigiGrade completeness score across reporting means revealed no statistically significant differences (p = 0.094 > 0.05). Conclusion: Electronic reporting shows quantitative effectiveness and consistent quality. Its adoption remains limited and requires continuous strengthening, particularly through increased awareness among pharmaceutical companies
- 27 February 2025
- Published by SAGE Publications in Hospital Pharmacy
- Vol. 60 (4) , 338-352
Assessment of Automation Models in Hospital Pharmacy: Systematic Review of Technologies, Practices, and Clinical Impacts
Medication management in hospitals is a complex process that encompasses every step from prescription to administration, involving multiple healthcare professionals. This process is prone to various errors that can compromise patient safety and generate significant human and financial costs. Automation in hospital pharmacies represents a major advancement, enhancing patient safety, optimizing professional practices, and reducing hospital expenses. This study aims to analyze the different types of automation systems used in hospital pharmacies, assess the impact of automation, and explore its benefits as well as the challenges and limitations associated with its implementation. A literature search was conducted using the ScienceDirect, PubMed, and Scopus databases, covering the period from 1992 to 2024. A total of 129 relevant articles related to the automation of medication preparation and distribution, as well as its challenges and perspectives were included in this study. Automated technologies significantly contribute to reducing medication errors, strengthening traceability, optimizing inventory management, and alleviating the workload of healthcare professionals. However, challenges persist, particularly in terms of costs, integration with existing processes, and staff training. The use of artificial intelligence offers promising prospects for improving the accuracy and operational efficiency of automation systems.
- 27 February 2025
- Published by SAGE Publications in Hospital Pharmacy
- Vol. 60 (4) , 338-352
Assessment of Automation Models in Hospital Pharmacy: Systematic Review of Technologies, Practices, and Clinical Impacts
Medication management in hospitals is a complex process that encompasses every step from prescription to administration, involving multiple healthcare professionals. This process is prone to various errors that can compromise patient safety and generate significant human and financial costs. Automation in hospital pharmacies represents a major advancement, enhancing patient safety, optimizing professional practices, and reducing hospital expenses. This study aims to analyze the different types of automation systems used in hospital pharmacies, assess the impact of automation, and explore its benefits as well as the challenges and limitations associated with its implementation. A literature search was conducted using the ScienceDirect, PubMed, and Scopus databases, covering the period from 1992 to 2024. A total of 129 relevant articles related to the automation of medication preparation and distribution, as well as its challenges and perspectives were included in this study. Automated technologies significantly contribute to reducing medication errors, strengthening traceability, optimizing inventory management, and alleviating the workload of healthcare professionals. However, challenges persist, particularly in terms of costs, integration with existing processes, and staff training. The use of artificial intelligence offers promising prospects for improving the accuracy and operational efficiency of automation systems.
- 31 October 2024
- Published by Elsevier in Annales Pharmaceutiques Françaises
- Vol. 83 (2) , 358-366
Self-medication of the pediatric population by parents in Morocco: Survey in the Midelt region
- 31 October 2024
- Published by Elsevier in Annales Pharmaceutiques Françaises
- Vol. 83 (2) , 358-366
Self-medication of the pediatric population by parents in Morocco: Survey in the Midelt region